The Lack of EpiPen Competitors is the FDA’s Fault

“There’s a new bout of outrage over an expensive medicine or medical treatment. While the good in question changes each time, the blame always seems to fall on greedy corporation…”

Source: The Lack of EpiPen Competitors is the FDA’s Fault

This entry was posted in Federal Government, Innovation, Regulations. Bookmark the permalink.

Comments are closed.